These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23120773)

  • 1. [Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin].
    Pustokhanova LV; Morozova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4 Pt 2):23-7. PubMed ID: 23120773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuromidin in the treatment of cognitive impairment in the early rehabilitation period of ischemic stroke].
    Pustokhanova LV; Morozova EM; Selivokhina OI; Shiliaeva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3 Pt 2):47-52. PubMed ID: 23612399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of neuromidin in patients with minor ischemic stroke].
    Maksimova MIu; Sharov MN; Sineva NA; Vodop'ianov NP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):35-40. PubMed ID: 22224243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and hypothymia in post stroke patients.
    Pustokhanova L; Morozova E
    J Neurol Sci; 2013 Feb; 325(1-2):43-5. PubMed ID: 23235140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuromidin in the treatment of vascular cognitive disorders].
    Golovkova MS; Zakharov VV; Lifshits MIu; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):20-6. PubMed ID: 18379458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with movement and cognitive disorders in the residual period of stroke].
    Agafonov BV; Podrezova LA; Karavashkina EA; Vishniakova TI; Smirnova LA; Dadasheva MN; Shevtsova NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):55-8. PubMed ID: 21626819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits].
    Morozova MA; Beniashvili AG; Rupchev GE; Lepilkina TA; Starostin DS; Brusov OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):28-35. PubMed ID: 19008797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients.
    Bracco L; Bessi V; Padiglioni S; Marini S; Pepeu G
    J Alzheimers Dis; 2014; 40(3):737-42. PubMed ID: 24577458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rehabilitation of poststroke patients].
    Markin SP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):41-5. PubMed ID: 21630490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Barrow Neurological Institute screen for higher cerebral functions in cognitive screening after stroke.
    Redfors P; Hofgren C; Eriksson I; Holmegaard L; Samuelsson H; Jood K
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):349-55. PubMed ID: 23721621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterogeneity of cognitive disorders in the acute stage of the first ischemic carotid stroke].
    Kulesh AA; Shestakov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8 Pt 2):31-4. PubMed ID: 23390652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromidin in mixed vascular and Alzheimer's dementia].
    Damulin IV; Stepkina DA; Lokshina AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):40-3. PubMed ID: 21350422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cognitive functioning 1 year poststroke related to quality of life domain?
    Verhoeven CL; Post MW; Schiemanck SK; van Zandvoort MJ; Vrancken PH; van Heugten CM
    J Stroke Cerebrovasc Dis; 2011; 20(5):450-8. PubMed ID: 20813551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive disorders in stroke patients: the possibilities of pharmacological correction].
    Belskaya GN; Chuprina SE; Vorobyev AA; Gorozha EN; Butorakina TL; Sokolov MA; Izmaylov IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):33-37. PubMed ID: 27240178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning, behavior, and quality of life after stroke in childhood.
    Everts R; Pavlovic J; Kaufmann F; Uhlenberg B; Seidel U; Nedeltchev K; Perrig W; Steinlin M
    Child Neuropsychol; 2008 Jul; 14(4):323-38. PubMed ID: 18568780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of ipidacrinum (neuromidin) in mononeuropathies].
    Bel'skaia GN; Popov DV; Gusev VV; Tikhomirova IN; Lukashevich IG; L'vova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):31-2. PubMed ID: 23250595
    [No Abstract]   [Full Text] [Related]  

  • 18. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is 25(OH)D Associated with Cognitive Impairment and Functional Improvement in Stroke? A Retrospective Clinical Study.
    Yalbuzdag SA; Sarifakioglu B; Afsar SI; Celik C; Can A; Yegin T; Senturk B; Guzelant AY
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1479-86. PubMed ID: 25922112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery after brain damage: Is there any indication for generalization between different cognitive functions?
    Richter KM; Mödden C; Hanken K; Hildebrandt H
    J Clin Exp Neuropsychol; 2015; 37(6):571-80. PubMed ID: 26059257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.